AIPLA Submits Comments Regarding the China National Intellectual Property Administration (CNIPA) Administrative Adjudication Measures for Early Resolution Mechanism for Drug Patent Disputes March 26, 2021

File Downloads

All documents are in PDF format.

On March 26, 2021, AIPLA submitted comments regarding the China National Intellectual Property Administration (CNIPA) Administrative Adjudication Measures for Early Resolution Mechanism for Drug Patent Disputes. In the comments, AIPLA requests clarification of handling of patent invalidity challenges, since substantial ambiguity remains concerning the handling of patent validity challenges.

AIPLA recommends amending the Draft Measures to clarify whether patent validity in linkage adjudications is limited to promptly incorporating determinations of invalidity by CNIPA RID under the established regulations. Otherwise, AIPLA requests that the Draft Measures specify precisely which tribunals are authorized to determine patent validity.

AIPLA requests that the Draft Resolution Mechanism be further revised to provide the patentee an opportunity to correct any non-critical deficiencies in its complaint. AIPLA is concerned that no deadline is specified to complete the adjudication in the Draft Measures, and as such, suggests an 8-month deadline. Additionally, AIPLA requests a clear statement that such mediation will not delay the administrative adjudication.

Article 11 provides a notice period of “at least 3 working days before the oral hearing,” which seems impractically short, particularly for foreign entities. AIPLA suggests extending this period to at least 10 working days. Article 17 provides: “15 days after receipt of the administrative adjudication decision” for filing an appeal to a court, whereas AIPLA suggests extending this period to 3 months.

AIPLA requests that the Draft Measures include a corresponding provision providing that if a case has been accepted by either CNIPA or the People’s Court, any case subsequently filed in the other tribunal shall not be accepted on the same asserted claims. AIPLA also requests that the Draft Measures provide that different claims, not asserted in the first accepted case, may be accepted in the second tribunal. Finally, AIPLA requests that all possible appeals have been resolved or the time within which to appeal has expired without an appeal being filed.

To read the full comments, please download the file.

Upcoming Events

  • 2025 Leadership Forum

    January 29 to 30, 2025

    AIPLA Leadership Forum – Elevate Yourself, Inspire the Future. This invitation-only two-day program will address building strong leadership skills for all levels of experience. See the program page for important event details.
  • 2025 Patent Prosecution Boot Camp - Arlington, VA

    March 5 to 7, 2025

    Register today and don't miss out! The 2025 Patent Prosecution Boot Camp is a comprehensive, CLE-accredited seminar that includes instructional lecture-style sessions with practical tips on U.S. and international patent preparation and prosecution, as well as hands-on interactive workshops that will walk you through drafting claims and responding to office actions. REGISTRATION IS NOW OPEN!
  • 2025 Trade Secret Summit

    March 27 to 28, 2025

    Registration is now open! The AIPLA Trade Secret Summit is the leading trade secret conference in the nation, with speakers from across the spectrum of private practitioners, in-house counsel, government, and academia, as well as fantastic networking opportunities. CLE credits will be available. REGISTRATION IS NOW OPEN!
  • 2025 AIPLA Spring Meeting

    May 13 to 15, 2025

    Save the Date! The 2025 Spring Meeting is a 2.5 day conference focused on trending topics in IP law. Registration opens February 2025.